Breaking News Instant updates and real-time market news.

2017-05-18 07:41:58 SNPS Synopsys $73.40 -1.725 (-2.30%) , CDNS Cadence Design $32.39 -0.85 (-2.56%) 07:41 05/18/17 05/18 07:41 05/18/17 07:41	Synopsys price target raised to $82 from $73 at Credit Suisse Credit Suisse analyst Farhan Ahmad noted that Synopsys (SNPS) reported better than expected Q2 results and raised FY17 guidance modestly. He views the company as the fastest growing electronic design automation, or EDA, company, adding that he continues to believe it has faster growth than Cadence Design (CDNS) due to its higher exposure to faster growth intellectual property and software businesses. Ahmad raised his price target on Synopsys to $82 from $73 and keeps an Outperform rating on the shares. SNPS Synopsys $73.40 -1.725 (-2.30%) CDNS Cadence Design $32.39 -0.85 (-2.56%)	22 May 01 Jun 06 Jun 06 Jun
SNPS CDNS SNPS Synopsys $73.40 -1.725 (-2.30%) 12/01/16 NEED 12/01/16 NO CHANGE Target $66 NEED Buy Synopsys price target raised to $66 from $60 at Needham Needham analyst Richard Valera raised his price target for Synopsys to $66 from $60 after the company delivered "strong" Q4 results. While the company's down year over year backlog despite an increase in duration will likely raise some questions, the analyst is inclined to give Synopsys the benefit of the doubt given its strong recent execution track record. He reiterates a Buy rating on the shares, and says he would a buyer on any post-earnings weakness. 10/19/16 FBCO 10/19/16 INITIATION Target $68 FBCO Outperform Synopsys initiated with an Outperform at Credit Suisse Credit Suisse analyst Farhan Ahmad initiated Synopsys with an Outperform and a $68 price target saying it is the largest EDA company and will benefit as Semi growth shifts to IoT/IAI from consumer. Ahmad expects Synopsys' differentiated products will enable it to improve operating margins to 25% by FY17 from 22% in CY15, and to continue to increase market share in EDA. 10/10/16 DADA 10/10/16 NO CHANGE DADA Synopsys price target raised to $100 from $75 at DA Davidson DA Davidson analyst Thomas Diffely raised his price target on Synopsys citing "solid EDA industry fundamentals" and the "strong operating models" of companies in the sector. Given these factors, Diffely, who identifies Synopsys as his favorite EDA name, thinks that the company deserves a higher multiple. He keeps a Buy rating on the stock. 08/18/16 NEED 08/18/16 NO CHANGE Target $60 NEED Buy Synopsys price target raised to $60 from $54 at Needham Needham analyst Richard Valera raised his price target for Synopsys to $60 from $54 after the company delivered upside top and bottom line results in Q3 and increased its 2016 guidance. The analyst believes Synopsys is gaining share in its hardware business, while also "holding its own" on renewals with its consolidated semi customers. Valera expects the company to continue to perform "solidly" despite the tough macro backdrop. He reiterates a Buy rating on the shares. CDNS Cadence Design $32.39 -0.85 (-2.56%) 04/25/17 FBCO 04/25/17 NO CHANGE Target $31 FBCO Neutral Cadence Design price target raised to $31 from $25 at Credit Suisse Credit Suisse analyst Farhan Ahmad raised his price target for Cadence Design to $31 from $25 after the company beat Street estimate for Q1 EPS but guided Q2 EPS below consensus. The analyst reiterates a Neutral rating on the shares. 04/25/17 DADA 04/25/17 DOWNGRADE Target $32 DADA Neutral Cadence Design downgraded to Neutral from Buy at DA Davidson DA Davidson analyst Thomas Diffely downgraded Cadence Design to Neutral saying the valuation now reflects the company's bullish outlook. The analyst raised his price target for the shares to $32 from $30 following Cadence's Q1 results. 12/12/16 JPMS 12/12/16 DOWNGRADE Target $25 JPMS Underweight Cadence Design downgraded to Underweight from Neutral at JPMorgan JPMorgan analyst Sterling Auty downgraded Cadence Design Systems to Underweight saying the shares are at a premium valuation level, which is unsustainable. The analyst keeps a $25 price target for the shares. 10/19/16 FBCO 10/19/16 INITIATION Target $25 FBCO Neutral Cadence Design initiated with a Neutral at Credit Suisse Credit Suisse analyst Farhan Ahmad initiated Candence Design with a Neutral and a $25 price target citing premium valuation and high 2017 expectations.

2017-05-18 07:41:58

SNPS

Synopsys

$73.40: -1.725 (-2.30%)

, CDNS

Cadence Design

$32.39: -0.85 (-2.56%)

07:41

05/18/17

05/18

07:41

05/18/17

07:41

Synopsys price target raised to $82 from $73 at Credit Suisse

Credit Suisse analyst Farhan Ahmad noted that Synopsys (SNPS) reported better than expected Q2 results and raised FY17 guidance modestly. He views the company as the fastest growing electronic design automation, or EDA, company, adding that he continues to believe it has faster growth than Cadence Design (CDNS) due to its higher exposure to faster growth intellectual property and software businesses. Ahmad raised his price target on Synopsys to $82 from $73 and keeps an Outperform rating on the shares.

SNPS

Synopsys

$73.40: -1.725 (-2.30%)

CDNS

Cadence Design

$32.39: -0.85 (-2.56%)

22
May
01
Jun
06
Jun
06
Jun

SNPS
CDNS

SNPS Synopsys

$73.40: -1.725 (-2.30%)

12/01/16: NEED

10/19/16: FBCO

10/10/16: DADA

08/18/16: NEED

CDNS Cadence Design

$32.39: -0.85 (-2.56%)

04/25/17: FBCO

04/25/17: DADA

12/12/16: JPMS

10/19/16: FBCO

TODAY'S FREE FLY STORIES

EXAS Exact Sciences $32.65 -0.67 (-2.01%) , UNH UnitedHealth $176.59 -0.91 (-0.51%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Recommendations	Exact Sciences, UnitedHealth analyst commentary » Exact Sciences remains a… EXAS Exact Sciences $32.65 -0.67 (-2.01%) UNH UnitedHealth $176.59 -0.91 (-0.51%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 31 May 06 Jun
QCOM Qualcomm $57.34 -0.18 (-0.31%) , NXPI NXP Semiconductors $108.14 0.14 (0.13%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Hot Stocks	Qualcomm extends cash tender offer for NXP Semiconductors outstanding shares » Qualcomm (QCOM) announced… QCOM Qualcomm $57.34 -0.18 (-0.31%) NXPI NXP Semiconductors $108.14 0.14 (0.13%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun 09 Jun
FRO Frontline $5.41 -0.22 (-3.91%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Upgrade	Frontline rating change » Frontline upgraded to Buy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EGHT 8x8, Inc. $13.60 0.1 (0.74%) 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Conference/Events	8x8, Inc. management to meet with Needham » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 01 Jun 06 Jun 06 Jun 08 Jun 13 Jun
GNRT Gener8 Maritime $4.91 0.06 (1.24%) , FRO Frontline $5.41 -0.22 (-3.91%) … 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Recommendations	Gener8 Maritime, Frontline, DHT Holdings analyst commentary » Gener8 Maritime advance… GNRT Gener8 Maritime $4.91 0.06 (1.24%) FRO Frontline $5.41 -0.22 (-3.91%) DHT DHT Holdings $4.20 -0.07 (-1.64%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

WLL Whiting Petroleum $7.28 -0.69 (-8.66%) , ORCL Oracle $45.42 0.16 (0.35%) 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Options	Unusual put flow in option market yesterday » Notable put activity was… WLL Whiting Petroleum $7.28 -0.69 (-8.66%) ORCL Oracle $45.42 0.16 (0.35%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:25 05/31/17 05/31 07:25 05/31/17 07:25 Technical Analysis	Technical View: Michael Kors drops to new 52-week low after earnings » In the pre-market the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
CBS CBS $61.52 -0.05 (-0.08%) , CBS.A $63.50 -0.15 (-0.24%) … 07:24 05/31/17 05/31 07:24 05/31/17 07:24 Periodicals	Scott Pelley to depart anchor role on 'CBS Evening News,' NY Times says » CBS (CBS, CBS.A) news… CBS CBS $61.52 -0.05 (-0.08%) CBS.A $63.50 -0.15 (-0.24%) CMCSA Comcast $41.10 0.19 (0.46%) CMCSK Comcast DIS Disney $108.34 -0.07 (-0.06%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun 08 Jun 15 Jun
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:23 05/31/17 05/31 07:23 05/31/17 07:23 Hot Stocks	Breaking Hot Stocks news story on Michael Kors » Michael Kors drops 7% in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
UAA Under Armour $19.56 -0.13 (-0.66%) 07:23 05/31/17 05/31 07:23 05/31/17 07:23 Recommendations	Under Armour analyst commentary » Under Armour has reached… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May

07:22 05/31/17 05/31 07:22 05/31/17 07:22 General news	Futures higher ahead of final trading for May » Stock futures are above… Stock futures are above fair value as the final trading session of May is set to begin. World markets closed trading with gains for the month as investors stateside will be looking ahead to Friday's nonfarm payrolls report. Today though they will see the Chicago purchasing manager's report and pending home sales data. The weekly oil numbers, which are normally released on Wednesday, will be delayed until tomorrow due to the Memorial Day holiday. In early trading, Dow futures are 18 points above fair value, Nasdaq futures are 12 points above fair value and S&P futures are 2 points above fair value.
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:22 05/31/17 05/31 07:22 05/31/17 07:22 Hot Stocks	Michael Kors says to close 100-125 full-price retail stores over next two years » Michael Kors announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
MYL Mylan $39.36 -0.36 (-0.91%) 07:19 05/31/17 05/31 07:19 05/31/17 07:19 Recommendations	Mylan analyst commentary » Pension fund campaign a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Sep 09 Oct
VIAB Viacom $35.05 -0.08 (-0.23%) , VIA Viacom $38.90 0.5 (1.30%) 07:17 05/31/17 05/31 07:17 05/31/17 07:17 Recommendations	Viacom, Viacom analyst commentary » Viacom price target… VIAB Viacom $35.05 -0.08 (-0.23%) VIA Viacom $38.90 0.5 (1.30%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
XXII 22nd Century $1.37 -0.02 (-1.44%) 07:17 05/31/17 05/31 07:17 05/31/17 07:17 Hot Stocks	22nd Century reports 'dramatic surge' in VLN tobacco clinical trials, science » 22nd Century Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

ABT Abbott $45.00 0.29 (0.65%) 07:16 05/31/17 05/31 07:16 05/31/17 07:16 Recommendations	Abbott analyst commentary » Abbott making progress, … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GRMN Garmin $52.11 -0.29 (-0.55%) 07:15 05/31/17 05/31 07:15 05/31/17 07:15 Hot Stocks	Garmin launches Approach S60 golf watch » Garmin International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SLCA U.S. Silica $36.45 -0.76 (-2.04%) 07:15 05/31/17 05/31 07:15 05/31/17 07:15 Technical Analysis	Technical View: U.S. Silica trades higher in pre-market » In the pre-market the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Jun
GPRK GeoPark $8.71 -0.18 (-2.02%) 07:12 05/31/17 05/31 07:12 05/31/17 07:12 Hot Stocks	GeoPark names Coulter Enterprises Chairman and CEO Coulter to board » GeoPark Limited announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PRQR ProQR Therapeutics $4.70 -0.3 (-6.00%) 07:12 05/31/17 05/31 07:12 05/31/17 07:12 Hot Stocks	ProQR Therapeutics' QR-110 granted Fast Track designation by FDA » ProQR Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

MOH Molina Healthcare $66.30 -0.57 (-0.85%) 07:11 05/31/17 05/31 07:11 05/31/17 07:11 Downgrade	Molina Healthcare rating change » Molina Healthcare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GSK GlaxoSmithKline $43.41 0.74 (1.73%) 07:11 05/31/17 05/31 07:11 05/31/17 07:11 Technical Analysis	Technical View: GlaxoSmithKline rises in early trading » Shares were last up over… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Jun
RGNX Regenxbio $16.70 -1.3 (-7.22%) 07:09 05/31/17 05/31 07:09 05/31/17 07:09 Earnings	Regenxbio initiates Phase 1 clinical trial of RGX-314 for macular degeneration » Regenxbio has dosed the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
INCY Incyte $130.49 -3.89 (-2.89%) 07:08 05/31/17 05/31 07:08 05/31/17 07:08 Recommendations	Incyte analyst commentary » Incyte price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	02 Jun 13 Jun 15 Jun
TRIL Trillium Therapeutics $5.05 0.05 (1.00%) 07:08 05/31/17 05/31 07:08 05/31/17 07:08 Hot Stocks	Trillium to present TTI-621 immune checkpoint inhibitor program at ASCO » Trillium Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 08:00

Fed Bank President Kaplan Takes Part in a Discussion Government Event

New York, NY
JILL
Today at 08:00

J.Jill - JILL Conference Calls
KORS
Today at 08:00

Michael Kors - KORS Conference Calls
BWFG
Today at 08:00

Bankwell Financial Firm Sponsored Meetings

Woodway Country Club--540 Hoyt Street, Darien, CT
CUBE
Today at 08:00

CubeSmart Firm Sponsored Meetings

Co Offices--5 Old Lancaster Road, Malvern, PA
SCOR
Today at 08:30

comScore - SCOR Conference Calls
PRGO
Today at 08:30

Perrigo - PRGO Conference Calls
NVS
Today at 08:30

Novartis Firm Sponsored Meetings
ONCE
Today at 08:30

Spark Therapeutics Firm Sponsored Meetings

Offices of Ballard Spahr LLP--1735 Market Street, Philadelphia, PA
Today at 08:55

Redbook Store Sales Y/Y: Week 5/27 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ARI X ARI Apollo Commercial Spot Secondary Managers: Citi, JPMorgan, BofA/Merrill & Morgan Stanley $18.25-18.60 1.2M Shares JRVR X JRVR James River Group Spot Secondary Managers: Morgan Stanley $40.00-41.00 4.25M Shares STAY X STAY Extended Stay America Spot Secondary Managers: Morgan Stanley & Citi $17.50-17.60 2.5B Shares
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Synopsys price target raised to $82 from $73 at Credit Suisse

TODAY'S FREE FLY STORIES

Get Full Fly Access